| abstract |
The present invention provides a compound that: has a lysine-specific demethylase-1-inhibiting effect; and provides utility as a drug for preventing or treating schizophrenia, Alzheimer's disease, Parkinson's disease, and Huntington chorea. The present invention pertains to a compound expressed by formula (1) or salt thereof (where (A) represents a hydrocarbon group optionally having a substitution group or a heterocyclic group optionally having a substitution group; (B) represents a benzene ring optionally having a substitution group; (R1), (R2), and (R3) independently represent a hydrogen, a hydrocarbon group optionally having a substitution group, or a heterocyclic ring group optionally having a substitution group; (A) and (R1) can be bonded together to form, with an adjacent nitrogen atom, a cyclic group optionally having a substitution group; and (R2) and (R3) can be bonded together to form, with an adjacent hydrogen atom, a cyclic group optionally having a substitution group). |